儿童急性髓性白血病的临床试验
总计6742个结果
-
Amgen主动,不招人
-
Arog Pharmaceuticals, Inc.招聘中
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Spectrum Pharmaceuticals, Inc终止
-
M.D. Anderson Cancer Center招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)暂停
-
National Cancer Institute (NCI)完全的治疗相关的急性髓性白血病 | 具有 FLT3/ITD 突变的急性髓性白血病 | FLT3基因突变 | 伴有 PML-RARA 的急性早幼粒细胞白血病 | 具有 Inv(16)(p13.1q22) 或 t(16;16)(p13.1;q22) 的急性髓性白血病; CBFB-MYH11 | 急性髓性白血病伴 t(8;21); (q22; q22.1); RUNX1-RUNX1T1美国
-
Imbioray (Hangzhou) Biomedicine Co., Ltd.The First Affiliated Hospital of Soochow University尚未招聘
-
The First Affiliated Hospital with Nanjing Medical...Huai'an First People's Hospital; Yancheng First People's Hospital招聘中
-
920th Hospital of Joint Logistics Support Force...Gracell Biotechnology Shanghai Co., Ltd.招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteJazz Pharmaceuticals招聘中
-
Rigshospitalet, DenmarkVestre Viken Hospital Trust; Karolinska University Hospital; Helsinki University Central Hospital 和其他合作者招聘中
-
TC Biopharm招聘中
-
Guy's and St Thomas' NHS Foundation TrustKing's College London招聘中
-
The First Affiliated Hospital with Nanjing Medical...Huai'an First People's Hospital; Yancheng First People's Hospital; The Affiliated Jiangning Hospital...招聘中
-
Centre Hospitalier Universitaire de NiceJazz Pharmaceuticals; Acute Leukemia French Association招聘中
-
Xinqiao Hospital of ChongqingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.尚未招聘
-
Nantes University Hospital招聘中
-
Zhejiang UniversityYake Biotechnology Ltd.尚未招聘
-
Zhejiang UniversityFirst People's Hospital of Hangzhou; Second Affiliated Hospital, School of Medicine, Zhejiang... 和其他合作者招聘中
-
Shanghai Jiao Tong University School of Medicine尚未招聘
-
Shanghai Unicar-Therapy Bio-medicine Technology...招聘中
-
Novartis Pharmaceuticals完全的急性髓性白血病意大利, 克罗地亚, 爱沙尼亚, 捷克语, 法国, 西班牙, 瑞典, 保加利亚, 立陶宛, 塞尔维亚, 匈牙利, 芬兰, 挪威, 罗马尼亚, 斯洛伐克
-
H. Lee Moffitt Cancer Center and Research InstituteMinneamrita Therapeutics LLC终止
-
Celgene主动,不招人白血病,骨髓,急性美国, 澳大利亚, 巴西, 加拿大, 捷克语, 芬兰, 法国, 德国, 意大利, 大韩民国, 墨西哥, 葡萄牙, 俄罗斯联邦, 西班牙, 英国, 比利时, 台湾, 奥地利, 爱尔兰, 以色列, 立陶宛, 波兰, 火鸡
-
National Cancer Institute (NCI)主动,不招人
-
John QuigleyPfizer; AbbVie主动,不招人
-
Sumitomo Pharma America, Inc.完全的
-
Boehringer Ingelheim完全的